MARTINDALE: The Complete Drug Reference (2 Volume Set)

Printed in two volumes

• Volume A - Drug Preparations
• Volume B - Preparations, Manufacturers, Pharmaceutical Terms in Various Languages & General Index

The world""s most comprehensive reference source about drugs and medicines. The 41st edition of Martindale: The Complete Drug Reference, will be fully updated and provide practical, evidencebased, global guidance, allowing healthcare professions to quickly understand the characteristics of drugs and their clinical uses.

Breadth: No other source of drug information contains the wide range of content or the same level of detail

Global coverage: The leading resource in terms of international content, including information from over 43 countries

Objectivity: Respected for the accuracy of content, appraised and authored by experts with editorial independence from the pharmaceutical industry. Based on information from published papers, regulatory sources and guidelines, with extensive referencing

International adoption: Recognised, trusted and adopted worldwide Martindale is depended upon by health professionals worldwide for its reliable and comprehensive information on international drugs and medicines. It is widely recognised for its unbiased and authoritative nature, as well as its unprecedented international coverage. A team of experts use the most clinically relevant and reliable information, giving health professionals a complete resource for reference on drugs and medicines.

Martindale remains the leading international resource, respected for its objectivity, reliability and global coverage, it's unique offering:

• Includes encyclopaedic facts about drugs and medicines:
• Over 6,600 monographs on drugs and ancillary substances
• Over 200,000 preparations
• Over 60,000 references
• Over 25,000 manufacturers and distributors
• Enables identification of medicines, the local equivalent, and the manufacturer
• Covers herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons
• Evidence-based and extensively referenced

NEW FOR THE 41ST EDITION - OVER 130 MONOGRAPHS INCLUDING:

• New antivirals such as fostemsavir and lenacapavir for multi-drug resistant HIV infection and bulevirtide for hepatitis D
• New biological treatments for type 1 diabetes (teplizumab), non-neovascular (dry) age-related macular degeneration (pegcetacoplan), and spinal muscle atrophy type 1 (onasemnogene abeparvovec)
• New class of drugs for migraine management: the calcitonin gene-related peptide (CGRP) receptor antagonists atogepant, rimegepant, ubrogepant, and zavegepant
• New content on management of COVID-19 including a new disease treatment review, COVID-19 infections, new monographs for the antivirals molnupiravir, nirmatrelvir, and remdesivir, and for COVID-19 vaccines, and updates to uses of baricitinib and tocilizumab
• Updated content on malaria and dengue vaccines

COMMENTARIES ON MARTINDALE CONTENT:

‘…Martindale is one of the key resources in my day-to-day work in providing clinicians and consumers with comprehensive responses to their medicine’s enquiries.’

Senior Pharmacist – Medicines Information, Australia

‘...an invaluable source of information for clinicians, pharmacists, pharmacologists and toxicologists and anyone interested in researching all there is to know about a certain drug,’  Australian Prescriber

‘...Martindale is the key reference for reputable, referenced and unbiased information. It is easy to find information, check products and precautions, and is immensely readable...’  Nursing Standard

‘...the Martindale is a true universal reference and its information wealth is unparalleled...a pharmacist can also not live without.’   Int J Clin Pharmacy